B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Kendrick Nguyen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Nomis Center for Immunobiology and Microbial Pathogenesis, Salk Cancer Center, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Univer…. Hauptthemen laut MEDLINE: CD40 Antigens, CD8-Positive T-Lymphocytes, B-Lymphocytes. Die Arbeit nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nomis Center for Immunobiology and Microbial Pathogenesis, Salk Cancer Center, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; University of California, San Diego, School of Biological Sciences, San Dieg…
- Nomis Center for Immunobiology and Microbial Pathogenesis, Salk Cancer Center, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
- Nomis Center for Immunobiology and Microbial Pathogenesis, Salk Cancer Center, Salk Institute for Biological Studies, La Jolla, CA 92037, USA; Waitt Advanced Biophotonics Center Core Facility, Salk Institute for Biologi…
- University of California, San Diego, Department of Radiation Medicine & Applied Sciences, San Diego, CA 92093, USA.
- Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
- BC Cancer Deeley Research Centre, Victoria, BC V8R 6V5, Canada.
Förderung
- NIA NIH HHS
- NIH HHS
- NCI NIH HHS
- The Susan G Komen Breast Cancer Foundation Inc
- Salk Institute for Biological Studies
- California Breast Cancer Research Program
- Newman Family Foundation
- Waitt Foundation
Zitieren
APA
Nguyen, K., Quackenbush, M., Basbous, S., Rodriguez, H., Lattanzi, G., Quansah, E., Bowman, C., Novak, S. W., Boassa, D., Yu, J., Ozbun, T., Lui, A., Thennavan, A., Watson, P., Wehner, A., & Hollern, D. (2026). B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117957
Vancouver
Nguyen K, Quackenbush M, Basbous S, Rodriguez H, Lattanzi G, Quansah E, et al. B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117957
BibTeX
@article{Nguyen2026,
author = {Nguyen, Kendrick and Quackenbush, Monika and Basbous, Sara and Rodriguez, Haley and Lattanzi, Georgia and Quansah, Elsie and Bowman, Chynna and Novak, Sammy Weiser and Boassa, Daniela and Yu, Jingting and Ozbun, Taylor and Lui, Asona and Thennavan, Aatish and Watson, Peter and Wehner, April and Hollern, Daniel},
title = {B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117957}
}
EUVIMED